Monthly CME Webinar: “Evaluating the Role and Impact of Primary Care Providers on the Treatment of Patients With Moderate-to-Severe Asthma”

The Louisiana Academy of Family Physicians cordially invites you to attend a CME presentation titled, “Evaluating the Role and Impact of Primary Care Providers on the Treatment of Patients With Moderate-to-Severe Asthma.”  This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.

Learning Objectives

1.  Define high intensity treatment in patients with asthma.
2.  Utilize clinical indicators to assess or refer patients for escalation of asthma therapy including add-on biologics.
3.  Analyze efficacy and safety data of available biologics for the treatment of asthma.
4.  Apply recommendation for biomarker testing in evaluation of patients with asthma.
5.  Implement strategies for effective management of patients with asthma with biologic therapies in collaboration with asthma specialists.

Registration

Attendance is free, but registration is required.  

Register Today!

Program Faculty

Nicola (Nick) A. Hanania, MD, MS

Dr. Hanania is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas. He also serves on the Executive Faculty Senate as the Clinical Science Representative at Baylor College of Medicine. He is the Chief of Section of Pulmonary, Critical Care and Sleep Medicine at Ben Taub Hospital. He completed his medical training at the University of Jordan in Amman, Jordan, followed by a residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto, Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master’s degree in clinical investigation.

Dr Hanania is fellow of the Royal College of Physicians and Surgeons of Canada, American College of Physicians, American College of Chest Physicians, European Respiratory Society and American Thoracic Society. He has received multiple awards, including the ACCP’s Distinguished Scholar in Respiratory Health, Baylor College of Medicine Master Clinician Award, ACCP distinguished CHEST educator (DCE), ACCP Humanitarian Award, Fulbright and Jaworski’s Faculty Excellence Award for Teaching and Evaluation, and the Award for Excellence in Teaching from the Department of Medicine at Baylor College of Medicine. He is editor-in-chief of Respiratory Medicine and is associate editor of the journal Lung. He serves on the editorial board of Chest, and COPD (J of COPD Foundation). Dr Hanania’s research interests focus on the pharmacology and management of asthma and COPD. He has published more than 320 peer-reviewed papers, book chapters, editorials, and reviews on these topics. His research has been funded by NIH, ALA and industry and focuses on clinical trials investigating novel treatments. He is principal investigator for the American Lung Association Airways Clinical Research Center and COPD Gene study at Baylor College of Medicine, as well as principal investigator or co-investigator in several clinical trials in asthma and COPD. Dr Hanania has been invited and has lectured widely at local, regional, national, and international meetings.